Please assess the completion status of the following clinical trial:

Trial Title: Verapamil vs Steroid to Prevent Keloid Recurrence

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patient undergoing surgical removal of keloid~* Patient 18 years old or greater~* Length of excisional scar after surgical removal of keloid between 2 and 10 cm~Exclusion Criteria:~* Keloid in face or hands~* Pregnancy or lactation~* Dementia~* Any heart or pulmonary condition~* Systemic treatment with beta-blockers, ACE-inhibitors or calcium antagonists~* Systemic corticosteroidal therapy~* Intralesional steroid treatment within 2 months of surgery to remove keloid~* Flap surgery~* Lesions to face, hands and other cosmetically sensitive areas

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Verapamil (Type: ACTIVE_COMPARATOR): Verapamil 2.5 mg/mL injection sc intralesionally
- Kenalog 10 (Type: ACTIVE_COMPARATOR): Kenalog 10 mg/mL injection sc intralesionally

Based on this trial design, predict the completion outcome and termination type (if applicable).